Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (291-300 of 548) with videos related to

Pageof 55
Sort By:
British Journal of Pharmacology|November 1, 1979
Stereoselective blockade of cerebral dopamine receptors by sulpiride and sultopride [proceedings]A Clow, P Jenner, C D Marsden, et al.
Brain Research|June 14, 1991
Serotonergic sprouting in the neostriatum after intrastriatal transplantation of fetal ventral mesencephalonY Takeuchi, T Sawada, S Blunt, et al.
Neuroscience|December 1, 1987
An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmosetC M Waters, S P Hunt, P Jenner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
P450 enzymes and Parkinson's disease: the story so farA G Riedl, P M Watts, P Jenner, et al.
Advances in Neurology|January 1, 1988
Animal models of neuroleptic-induced acute dystoniaB R Stewart, N M Rupniak, P Jenner, et al.
Biochemical Pharmacology|June 1, 1984
Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neuronesS Boyce, E Kelly, C Reavill, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1985
Does an endogenous methylpyridinium analogue cause Parkinson's disease?B Testa, R Naylor, B Costall, et al.
Neuroscience Letters|October 12, 1992
Striatal neuropeptide levels in Parkinson's disease patientsA Fernandez, M L de Ceballos, P Jenner, et al.
Psychopharmacologia|January 1, 1975
Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsA Dolphin, P Jenner, C D Marsden, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic studyB Y Zeng, R K Pearce, G M MacKenzie, et al.
Pageof 55

Showing results (291-300 of 548) with videos related to

Sort By:
Pageof 55
British Journal of Pharmacology|November 1, 1979
Stereoselective blockade of cerebral dopamine receptors by sulpiride and sultopride [proceedings]A Clow, P Jenner, C D Marsden, et al.
Brain Research|June 14, 1991
Serotonergic sprouting in the neostriatum after intrastriatal transplantation of fetal ventral mesencephalonY Takeuchi, T Sawada, S Blunt, et al.
Neuroscience|December 1, 1987
An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmosetC M Waters, S P Hunt, P Jenner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
P450 enzymes and Parkinson's disease: the story so farA G Riedl, P M Watts, P Jenner, et al.
Advances in Neurology|January 1, 1988
Animal models of neuroleptic-induced acute dystoniaB R Stewart, N M Rupniak, P Jenner, et al.
Biochemical Pharmacology|June 1, 1984
Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neuronesS Boyce, E Kelly, C Reavill, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1985
Does an endogenous methylpyridinium analogue cause Parkinson's disease?B Testa, R Naylor, B Costall, et al.
Neuroscience Letters|October 12, 1992
Striatal neuropeptide levels in Parkinson's disease patientsA Fernandez, M L de Ceballos, P Jenner, et al.
Psychopharmacologia|January 1, 1975
Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsA Dolphin, P Jenner, C D Marsden, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic studyB Y Zeng, R K Pearce, G M MacKenzie, et al.
Pageof 55